Material Basis of Ningmitai Capsule for the Treatment of Urinary Tract Infections Based on Network Pharmacology.

[Objectives] To study the main active components, targets and related pathways of Ningmitai capsule for the treatment of urinary tract infections (UTIs) based on network pharmacology. [Methods] The chemical components of Ningmitai capsule were collected through literature search, and the relevant target information of the components was sorted out. The UTIs-associated targets were also screened out using DisGeNET database and GeneCards database. Cytoscape 3.6.1 software and STRING platform were used to construct the protein-protein interaction (PPI) network, and MCODE plug-in in this software was used to analyze the action pathway and key targets of Ningmitai capsule for the treatment of UTIs. GO and KEGG pathway enrichment analysis of key targets was conducted using David database, and the component-target-pathway network diagram of Ningmitai capsule for the treatment of UTIs was established. [Results] A total of 37 active compounds, including salicylate, ferulic acid, baicalin, quercetin, apigenin and ellagic acid were screened from seven TCM components of Ningmitai capsule. There were 26 possible targets related to the treatment of UTIs, such as NFKB1, JUN, CTNNB1 and STAT3, which play an important role for the treatment of UTIs through prostate cancer, bladder cancer, pancreatic cancer and other signaling pathways. [Conclusions] The study provides a theoretical basis for the study of the mechanism of Ningmitai capsule in the treatment of UTIs. [ABSTRACT FROM AUTHOR]